AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 192 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,139,000 | +43.0% | 40,000 | +33.3% | 0.71% | +95.9% |
| Q2 2019 | $1,496,000 | -11.3% | 30,000 | +20.0% | 0.36% | -41.7% |
| Q1 2019 | $1,686,000 | +143.6% | 25,000 | +66.7% | 0.62% | +66.5% |
| Q4 2018 | $692,000 | -55.1% | 15,000 | -25.0% | 0.37% | -32.2% |
| Q3 2018 | $1,542,000 | -26.8% | 20,000 | -20.0% | 0.55% | -32.1% |
| Q2 2018 | $2,106,000 | +28.6% | 25,000 | +24.9% | 0.81% | +6.0% |
| Q1 2018 | $1,637,000 | +43.1% | 20,019 | 0.0% | 0.76% | +79.8% |
| Q4 2017 | $1,144,000 | – | 20,019 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
| Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
| Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
| ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
| Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
| ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
| Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |